Get the Daily Brief
Latest Biotech News
Genomics and Multiomics Research Progress
Recent advances in genomics and multiomics are reshaping understanding of biology and disease. The 1000 Genomes Project Long-Read Sequencing Consortium expanded efforts by adding PacBio sequencing...
Biopharma Fundraising and Market Trends
The biopharma sector shows mixed market signals amid fundraising and restructurings. Australian venture firm Brandon Capital closed its sixth fund at AU$439 million, the largest to date,...
Innovations in Diagnostic and Sequencing Technologies
Technological advances continue to enhance diagnostics and sequencing capabilities. Qiagen released a long-read target enrichment panel compatible with multiple NGS platforms for detailed genetic...
Med-Tech and Device Regulatory Updates and Market Moves
Recent med-tech developments include regulatory designations and market performance shifts. Cryofocus received FDA breakthrough device designation for its asthma cryoablation system, prompting...
Breakthroughs in Aging and Protein Biology
New research sheds light on aging dynamics and protein stability. A comprehensive proteomic analysis identified a critical inflection point at approximately 50 years of age when aging accelerates,...
Industry Leadership Changes and Strategic Movements
Key leadership and strategic developments are shaping industry trajectories. Thermo Fisher Scientific announced CFO Stephen Williamson's upcoming retirement, succeeded by Jim Meyer. Agilent...
Sarepta’s Duchenne Gene Therapy Faces Regulatory and Market Setbacks
Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy (DMD) has encountered significant challenges in both U.S. and European regulatory arenas. The FDA requested Sarepta halt...
Novartis, Lilly, and Collaborators Fueling Innovation Through Strategic Deals
Biopharma giants are strengthening pipelines through collaboration and investment. Novartis agreed to a $60 million upfront deal with Matchpoint Therapeutics to develop oral covalent inhibitors...
FDA and EMA Regulatory Updates Spotlight Approvals and Delays
Regulatory agencies continue to navigate complex reviews amid novel therapies and market dynamics. The FDA has extended its review of Bayer’s non-hormonal menopause drug elinzanetant by up to...
Cutting-Edge AI and Computational Biology Accelerate Drug Discovery
Artificial intelligence (AI) and computational models are significantly advancing biotech research. Cold Spring Harbor Laboratory introduced BATMAN, an AI model trained on a vast TCR-peptide...
Proteomic and Single-Cell Technologies Unveil New Insights in Biology and Disease
Recent proteomic and single-cell advances are transforming understanding of human aging, disease, and cellular heterogeneity. A comprehensive study revealed protein expression shifts accelerating...
Gene Therapy and Cell Therapy Landscape Evolves with New Trials and Pipeline Shifts
The gene and cell therapy sectors continue dynamic shifts with new clinical data and strategic realignments. AstraZeneca’s gefurulimab showed positive phase III results in generalized myasthenia...
Biopharma Financing and Venture Trends Reflect Market Challenges
The biotech investment landscape is experiencing contraction and concentration of capital. Brandon Capital Partners closed its largest life sciences fund at A$439 million ($290 million), targeting...
Leadership Changes Reshape Biopharma and Med-Tech Executives Ranks
Corporate leadership turnover continues in biotech and pharma. Bristol Myers Squibb announced AstraZeneca’s Cristian Massacesi will succeed Samit Hirawat as chief medical officer on August 1,...
Advances in Genomics and Long-Read Sequencing Illuminate Human Genetic Diversity
The 1000 Genomes Project continues to deepen insights into human genome complexity. The Long-Read Sequencing Consortium, led by the University of Washington, expanded its scope by integrating...
Emerging Technologies in Diagnostics and Viral Infection Monitoring
Innovative diagnostic technologies are emerging to improve clinical decision-making and infectious disease management. Geneoscopy received FDA clearance for an updated stool collection kit...
Bristol Myers Taps AstraZeneca’s Cristian Massacesi as New CMO
Bristol Myers Squibb named Cristian Massacesi, previously AstraZeneca's chief medical officer, as its new CMO effective August 1. Massacesi replaces Samit Hirawat, who contributed to launching...
FDA Seeks New Safety Studies for Sarepta’s Duchenne Gene Therapy Elevidys
The FDA requires Sarepta Therapeutics to perform new studies to confirm the safety of its Duchenne muscular dystrophy gene therapy Elevidys, after safety concerns led to a voluntary shipment...
European Medicines Agency Backs Lilly’s Alzheimer’s Drug and Gilead’s HIV Prevention Shot
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) reversed a prior negative decision and recommended approval for Eli Lilly’s Alzheimer's drug Kisunla for...
Deloitte Survey Highlights Industry Challenges from Tariffs and Pricing Policy Shifts
An extensive survey by Deloitte reveals life sciences firms confronting significant strategic and operational impacts due to evolving tariffs and pricing policies globally. About two-thirds of...